{"url_path":"/sec/jspr/8-k/2026-07-16/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1788028/0001213900-26-078781-index.html","accession_number":"0001213900-26-078781","cik":"0001788028","ticker":"JSPR","issuer_name":"Jasper Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1788028/0001213900-26-078781-index.html","primary_entity_key":"0001788028","primary_entity_name":"Jasper Therapeutics, Inc."},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01 - Financial Statements and Exhibits.**\n\n** **\n\n(c)Exhibits\n\n \n\n**Exhibit\nNumber**\n \n**Description**\n\n99.1\n \n[Press Release issued on July 16, 2026.](ea029831601ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n1\n\n \n\n** **\n\n**SIGNATURE**\n\n** **\n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**JASPER THERAPEUTICS, INC.**\n\n \n \n\nDate: July 16, 2026\nBy:\n /s/ Herb Cross\n\n \n \nName: \nHerb Cross\n\n \n \nTitle:\nChief Financial Officer\n\n \n\n2"}